ALMS גידול ברווח למניה בשנה הנוכחית Alumis Inc.
High barriers to entry and patent protection shield Alumis Inc. (ALMS) from the expansion of new players. This chart on GURU.Markets, showing the annual percentage growth of net income per share, demonstrates resilience, with the latest value recorded as -14.00. The diversification of research into autoimmune pathologies mitigates risks, while the strategy focuses on completing the final clinical phases of targeted drugs.
פילוחי מדדים פיננסיים ומדדי שוק עבור Alumis Inc. (ALMS)
The operational efficiency of Alumis Inc. (ALMS) is directly reflected in the rate of change in net earnings per share compared to the same period last year. This indicator measures fundamental growth in profitability, which, for this biotechnology company utilizing a full outsourcing model for production and trials, minimizes the impact of capital expenditures, as clearly demonstrated by this year-over-year EPS trend.
